Alumina-supported Molybdenum (VI) Oxide: An Efficient and Recyclable Heterogeneous Catalyst for Regioselective Ring Opening of Epoxides with Thiols, Acetic Anhydride, and Alcohols under Solvent-free Conditions
作者:Sweety Singhal、Suman L. Jain、Bir Sain
DOI:10.1246/cl.2008.620
日期:2008.6.5
An efficient and simple protocol for regioselective ring opening of epoxides with thiols, aceticanhydride, and alcohols using 16 wt % MoO3 supported on alumina as a recyclable catalyst is described.
A new process for preparing dialdehydes by catalytic oxidation of cyclic olefins with aqueous hydrogen peroxide
作者:Deng Jingfa、Xu Xinhua、Chen Haiying、Jiang Anren
DOI:10.1016/s0040-4020(01)88489-1
日期:1992.1
Dialdehydes were prepared by the reaction between cyclic olefins and aqueous hydrogenperoxidecatalyzed by tungsticacid. Glutaraldehyde and adipaldegyde were synthesized by this method with good yield. Several different conditions were tested.
HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
申请人:Hadida-Ruah Sara Sabina
公开号:US20110306607A1
公开(公告)日:2011-12-15
The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
申请人:HADIDA-RUAH Sara Sabina
公开号:US20140171427A1
公开(公告)日:2014-06-19
The invention relates to heterocyclic chromene-spirocyclic piperidine amides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
申请人:Nimbus Saturn, Inc.
公开号:US11028085B2
公开(公告)日:2021-06-08
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.